Conference
CANAGLIFLOZIN, A NEW ANTI-DIABETIC AGENT TARGETING CELLULAR METABOLISM, SUPPRESSES SURVIVAL AND ENHANCES THE RESPONSE OF NON-SMALL CELL LUNG CANCER (NSCLC) TO RADIOTHERAPY
Authors
Biziotis O-D; Tsakiridis E-E; Broadfield L; Farrell T; Menjolian G; Mathurin T; Mekhaeil B; Zacharidis P; Muti P; Abdulkarim B
Volume
139
Pagination
pp. S20-S20
Publisher
ELSEVIER IRELAND LTD
Publication Date
October 1, 2019
Name of conference
Annual Scientific Meeting of the Canadian-Association-for-Radiation-Oncology (CARO)
Conference place
Halifax, CANADA
Conference start date
October 2, 2019
Conference end date
October 5, 2019
Conference proceedings
RADIOTHERAPY AND ONCOLOGY
ISSN
0167-8140